EP-1043

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameEP-1043
Drug Alias NameRecombinant protein vaccine EP-1043EP-1043
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Genetically engineered subunit vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOnyvax LtdPharmexa-Epimmune
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOnyvax LtdNational Institute Of Allergy And Infectious Diseases (Niaid)Pharmexa-Epimmune
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A